Integrated dual diagnosis care means that mental health and substance use treatment are connected in the clinical plan. When comparing international programs, look beyond whether both services appear on the website. Ask how the team assesses the interaction between conditions, agrees on treatment priorities, reviews medication, and maintains care after discharge.
Integration can involve professionals working within one service or collaborating across services. The practical test is whether the patient receives a coherent plan with clear responsibility. Sharing an address, timetable, or brand name does not by itself show how clinical decisions are coordinated.
Clarify what dual diagnosis means in the proposal
NIMH describes co-occurring substance use and mental disorders as conditions that can occur together and influence care. Their relationship varies: shared factors, the effects of substances, or attempts to manage symptoms may be relevant. One explanation should not be assumed for every patient.
Ask which diagnoses or concerns the program expects to assess. A broad dual diagnosis label might refer to very different combinations, such as depression with alcohol use disorder, PTSD with substance use, or a psychotic disorder with another substance use problem.
The specific combination matters because it affects the treatment methods, medical needs, and level of care. A service experienced with one presentation should explain its capability for another. General confidence is less useful than a clear account of the relevant clinicians and interventions.
Begin with a shared assessment
NIMH recommends comprehensive assessment by professionals with experience in both mental health and substance use conditions. Symptoms can overlap, so the history should consider timing, previous episodes, substances, medication, physical health, and current functioning.
Ask how the program combines information from psychiatric assessment, addiction assessment, and existing records. The patient should not receive two unrelated explanations that never come together. The team should be able to describe its working understanding of the case and what remains uncertain.
A shared assessment does not require every question to be answered on the first day. It should identify immediate needs, initial treatment priorities, and areas for review. Ask how the team updates its understanding as the person participates in care and circumstances change.
Compare delivery models by what happens between appointments
SAMHSA describes coordinated, co-located, and fully integrated models of care. These terms provide a starting point, but prospective patients still need to understand the actual arrangement. Ask who owns the overall plan and how professionals communicate.
In coordinated care, services may work in different organizations. That can make sense when specialist expertise is needed, provided the connection is practical. Clarify how referrals are made, how records are shared with consent, and who follows up when one service recommends a change.
In a co-located arrangement, professionals work at the same site. Proximity may make communication easier, but ask whether they review the case together. Two appointments in one building can still leave the patient responsible for carrying clinical information between professionals.
For a fully integrated team, ask how its shared work is organized. Who attends case discussions? How is the patient involved? Which decisions require medical input? The program should explain its process without promising that every possible need can be handled internally.
| Coordination task | Evidence to request |
|---|---|
| Agreeing on priorities | A treatment plan showing how both conditions influence the initial goals. |
| Reviewing change | A process for discussing symptoms, substance use, medication, and functioning together. |
| Resolving conflicting advice | A named clinician or team responsible for reaching and explaining a decision. |
| Using outside services | Clear arrangements for referral, information transfer, and continuing responsibility. |
| Discharge planning | Connected follow-up for each ongoing clinical need. |
Distinguish clinical priorities from permanent exclusion
Some needs require prompt attention before other treatment can proceed. A medical complication or acute psychiatric concern may change the immediate setting or sequence of care. That is different from assuming that one diagnosis makes another condition ineligible for treatment indefinitely.
For PTSD and substance use disorder, the US National Center for PTSD describes evidence supporting treatment for both conditions, including appropriate trauma-focused care. It explains that the presence of one disorder should not automatically block access to evidence-based treatment for the other.
Ask how any proposed delay or sequence follows from the individual assessment. What needs to happen first, who will review progress, and what would allow the next treatment to start? An explicit clinical rationale is more useful than a fixed rule applied to every person with the same label.
Our PTSD and substance use comparison develops this example. The wider lesson is to examine how the program adapts care to the actual combination of conditions rather than assuming integration means every intervention begins simultaneously.
Keep each treatment specific enough to be useful
Integration should preserve appropriate treatment for each diagnosis. A general process group or broad emotional-support program may have a role, but it does not establish that a specific mental health disorder or substance use disorder is being treated adequately.
Ask the program to name the methods it proposes and explain the purpose of each. Which intervention addresses the mental health condition? Which addresses substance use? Where do they overlap, and where is distinct specialist work still needed?
NIMH describes behavioral treatments, appropriate medication, and care management as possible elements of co-occurring care. The combination depends on the person. A program should not imply that integration requires abandoning effective established treatment in favor of one universal approach.
For an eating disorder with substance use, medical and nutritional work may be central. Our program capability guide for that combination illustrates why a dual diagnosis claim needs to be tested against the actual clinical tasks.
Coordinate medication decisions
Ask who reviews all prescribed medicines, nonprescription products, supplements, and relevant substance use. The clinicians should have a common medication account and understand the purpose of each treatment. Separate prescribing decisions without communication can leave the patient unclear about the plan.
Clarify who can change a prescription and how changes are discussed with the patient and other treating professionals. Ask how benefits, unwanted effects, and practical difficulties are monitored. Do not change medication independently to fit an admissions policy.
For opioid use disorder, the CDC recommends appropriate medication treatment and states that declining psychosocial treatment should not prevent or delay access to medication. This is a useful example of why a program’s overall philosophy must be examined alongside substance-specific evidence.
When physical illness is also involved, ask how that clinician participates in decisions. Our chronic pain and substance use guide shows why the plan must preserve needed medical care while addressing the substance use problem.
Examine how the program handles difficulty
Ask what happens if symptoms worsen, the person returns to substance use, or participation becomes difficult. The response should involve reassessment of the clinical situation and needed support. Request a clear explanation of the program’s limits and any circumstances requiring transfer.
Find out who remains responsible if care moves to a hospital or another specialist service. A transfer should come with a clinical handover and a plan for what happens next. This is especially important abroad, where the patient may not have an established local care network.
Discuss how the patient can raise concerns about conflicting advice or treatment fit. Integration should make the plan easier to understand. It should not mean that the patient has no route to ask questions, request explanation, or seek another appropriate opinion.
Measure change across both conditions
Ask how the team reviews mental health symptoms, substance use goals, physical health, and functioning. Improvement in one area does not automatically show that every need has been met. A useful review makes progress and remaining problems visible.
Consider a hypothetical patient whose mood improves during a stay but who still lacks a workable substance use plan at home. Another may make progress with substance use while needing further psychiatric treatment. These examples show why a single overall success label can hide important next steps.
Our international clinical quality guide helps assess the evidence behind a program’s claims. Ask what its outcomes mean, when they are measured, and whether the information applies to people with the relevant combination of needs.
Carry integration across the border home
If family members participate, ask how they will receive one coherent explanation of the agreed support role. They should not be left trying to reconcile different messages from different parts of the program. With the patient’s consent, the team can clarify whom relatives should contact, what information may be shared, and which responsibilities belong to clinicians rather than the family.
Identify the receiving clinicians before discharge. Each should have the information needed to continue treatment, including the working formulation, methods used, medication decisions, remaining concerns, and agreed priorities. Ask who will connect the services if they work separately.
Confirm practical follow-up arrangements, not just a list of recommended services. If remote care is proposed, check that it can be provided where the patient will live and that it fits the clinical needs. Prescribing and therapy continuity may require different arrangements.
The aftercare guide provides a structure for this handover. A credible integrated program leaves the person with a connected pathway, including clear responsibility when the needs of one condition affect treatment for another.